Physician profile
Thomas W Link
NPI 1447520325
$29,711.93
in general payments reported to CMS, 2019-2025
12 companies · $670 in 2025
The $670 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,084 · 2020: $703 · 2021: $1,954 · 2022: $16K · 2023: $895 · 2024: $7,995 · 2025: $670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,000 · Food and Beverage: $2,559.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,000.00 |
| Food and Beverage | $2,559.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phenox INC. | $12,519.19 | 2020-2022 | |
| Qapel Medical INC | $8,363.90 | 2022-2025 | |
| Penumbra, INC. | $4,360.24 | 2020-2024 | Benchmark, Red 72, Smart Coil |
| Medtronic, INC. | $1,469.99 | 2021-2025 | Pipeline, Solitaire X, Onyx 18 |
| Microvention, INC. | $1,462.46 | 2019-2025 | Stent, Web Aneurysm Embolization System, Lvis Junior |
| Stryker Corporation | $669.14 | 2019-2025 | Adherus Autospray Dural Sealant, Na, Duramatrix |
| Balt USA, LLC | $492.16 | 2020-2025 | Carrier Delivery Catheter |
| Depuy Synthes Sales INC. | $263.47 | 2019 | |
| Zimmer Biomet Holdings, INC. | $49.32 | 2022 | |
| Route 92 Medical, INC. | $31.67 | 2025 | |
| Inspiremd LTD | $19.22 | 2025 | Cguard Prime Carotid Stent System |
| Cordis US Corp. | $11.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Link listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.